These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17261734)

  • 1. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA
    Stroke; 2007 Feb; 38(2 Suppl):763-7. PubMed ID: 17261734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
    Mayer SA; Rincon F
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S70-6. PubMed ID: 16427389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-early hemostatic therapy for primary intracerebral hemorrhage: a review.
    Mayer SA
    Can J Neurol Sci; 2005 Dec; 32 Suppl 2():S31-7. PubMed ID: 16450806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
    Mayer SA
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the risk of ICH enlargement.
    Wartenberg KE; Mayer SA
    J Neurol Sci; 2007 Oct; 261(1-2):99-107. PubMed ID: 17631908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
    Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
    J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
    Naidech AM; Grotta J; Elm J; Janis S; Dowlatshahi D; Toyoda K; Steiner T; Mayer SA; Khanolkar P; Denlinger J; Audebert HJ; Molina C; Khatri P; Sprigg N; Vagal A; Broderick JP
    Int J Stroke; 2022 Aug; 17(7):806-809. PubMed ID: 34427473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute stroke therapy. Current developments].
    Steiner T; Jüttler E; Ringleb P
    Nervenarzt; 2007 Oct; 78(10):1147-54. PubMed ID: 17879077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma].
    Rinkel GJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1827-9. PubMed ID: 16128178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
    Mayer SA; Davis SM; Skolnick BE; Brun NC; Begtrup K; Broderick JP; Diringer MN; Steiner T;
    Stroke; 2009 Mar; 40(3):833-40. PubMed ID: 19150875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
    Mayer SA; Brun NC; Broderick J; Davis SM; Diringer MN; Skolnick BE; Steiner T;
    Neurocrit Care; 2006; 4(3):206-14. PubMed ID: 16757825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
    Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
    JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of acute intracerebral hemorrhage.
    Anderson CS
    Curr Opin Crit Care; 2009 Apr; 15(2):93-8. PubMed ID: 19578319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Friedrich JO
    N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15901870
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.